Evolent Health, Inc.

NYSE EVH

Evolent Health, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD 134.38 M

Evolent Health, Inc. Operating Cash Flow is USD 134.38 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 51.16% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Evolent Health, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 88.90 M, a 358.04% change year over year.
Evolent Health, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 19.41 M, a 147.62% change year over year.
Evolent Health, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -40.76 M, a -515.37% change year over year.
Evolent Health, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 9.81 M, a 112.14% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

NYSE: EVH

Evolent Health, Inc.

CEO	Mr. Seth Barrie Blackley
IPO Date	June 5, 2015
Location	United States
Headquarters	800 North Glebe Road
Employees	4,700
Sector	Healthcare
Industries Hospitals & Clinics Biotechnology Dental Care Enterprise Resource Planning (ERP) Insurance Medical Instruments Software-as-a-Service (SaaS) Telehealth

Description

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Key trends

Past 5 years